- Thrombocytosis as a prognostic marker in stage III and IV serous ovarian cancer
-
Digklia A, Voutsadakis IA
- KMID: 2314011
- Obstet Gynecol Sci.
- 2014 Nov;57(6):457-463.
- doi: 10.5468/ogs.2014.57.6.457
OBJECTIVE: Thrombocytosis is an adverse prognostic factor in many types of cancer. We investigated if pre-treatment increased platelet counts provide prognostic information specifically in patients with stage III and IV... -
- CITED
-
- Close
- SHARE
-
- Close
